Active Ingredient History
Xanthophylls are yellow pigments that occur widely in nature and form one of two major divisions of the carotenoid group; the other division is formed by the carotenes. The name is from Greek: xanthos (ξανθός), meaning "yellow", and phyllon (φύλλον), meaning "leaf"), due to their formation of the yellow band seen in early chromatography of leaf pigments. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Carotid Artery Diseases (Phase 2/Phase 3)
Cataract (Phase 3)
Central Serous Chorioretinopathy (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 2)
Excipients ()
Genetic Diseases, Inborn (Phase 1/Phase 2)
Healthy Volunteers (Phase 1/Phase 2)
Infant, Newborn, Diseases (Phase 1/Phase 2)
Macula Lutea (Phase 4)
Macular Degeneration (Phase 3)
Parenting (Phase 3)
Retinitis Pigmentosa (Phase 3)
Vision, Entoptic (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue